Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4647 |  KPRX Kiora Pharmaceuticals, Inc. - Common Stock | 2.53 USD | 0.00% | -0.78% | +0.80% | +20.48% | 11.19 M USD | ||
| 4650 |  GDTC CytoMed Therapeutics Limited - Ordinary Shares | 0.94 USD | -4.08% | +17.50% | +10.59% | -58.22% | 11.12 M USD | ||
| 4651 |  VTGN Vistagen Therapeutics, Inc. - Common Stock | 0.25 USD | 0.00% | -13.79% | +4.17% | -51.92% | 11.09 M USD | ||
| 4653 |  TOVX Theriva Biologics, Inc. Common Stock | 0.24 USD | -4.00% | +4.35% | -4.00% | -4.00% | 11.01 M USD | ||
| 4659 |  LSTA Lisata Therapeutics, Inc. - Common Stock | 1.20 USD | +2.56% | -19.46% | -37.50% | -49.37% | 10.81 M USD | ||
| 4661 |  GTBP GT Biopharma, Inc. - Common Stock | 5.95 USD | -4.03% | -6.45% | -2.94% | +682.89% | 10.74 M USD | ||
| 4664 |  LTRN Lantern Pharma Inc. - Common Stock | 0.83 USD | -8.79% | -18.63% | -54.40% | -80.19% | 10.61 M USD | ||
| 4668 |  ADIL Adial Pharmaceuticals, Inc - Common Stock | 3.97 USD | -0.50% | -12.17% | -33.16% | +845.24% | 10.42 M USD | ||
| 4679 |  CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 1.39 USD | +2.21% | +6.92% | -49.45% | -6.08% | 10.00 M USD | ||
| 4681 |  SNTI Senti Biosciences, Inc. - Common Stock | 0.32 USD | -3.03% | +3.23% | 0.00% | -66.32% | 9.97 M USD | ||
| 4693 |  BLRX BioLineRx Ltd - American Depositary Shares | 2.22 USD | +0.45% | -4.72% | -14.29% | -21.00% | 9.66 M USD | ||
| 4695 |  BIVI BioVie Inc. - Common stock | 1.28 USD | -8.57% | -12.93% | -37.25% | +1.59% | 9.65 M USD | ||
| 4704 |  ENSC Ensysce Biosciences, Inc. - Common Stock | 0.46 USD | +6.98% | +12.20% | -4.17% | +21.05% | 8.95 M USD | ||
| 4705 |  QNRX Quoin Pharmaceuticals Ltd - American Depositary Shares | 4.55 USD | -3.19% | -5.41% | -35.83% | -51.18% | 9.14 M USD | ||
| 4708 |  IMRN Immuron Limited - American Depositary Shares | 1.11 USD | +1.83% | -0.89% | -35.47% | -47.64% | 8.96 M USD | ||
| 4711 |  MTVA MetaVia Inc. - Common Stock | 1.34 USD | -8.22% | -14.10% | -21.64% | +24.07% | 8.83 M USD | ||
| 4735 |  MBRX Moleculin Biotech, Inc. - Common Stock | 0.42 USD | -4.55% | -17.65% | -45.45% | -86.67% | 8.18 M USD | ||
| 4741 |  AZTR Azitra Inc Common Stock | 0.13 USD | 0.00% | 0.00% | -23.53% | -18.75% | 7.88 M USD | ||
| 4744 |  CNSP CNS Pharmaceuticals, Inc. - Common Stock | 5.35 USD | -1.47% | +2.29% | -7.60% | -45.80% | 7.82 M USD | ||
| 4751 |  SNGX Soligenix, Inc. - Common Stock | 0.35 USD | 0.00% | -5.41% | -7.89% | -69.03% | 7.62 M USD |
Notícias Biotechnology Stocks
Estudo da Lancet mostra alívio mais rápido com remédio da Pharvaris para AEH
Raymond James inicia cobertura da Kymera Therapeutics com recomendação acima da média
Raymond James inicia cobertura da Nektar com classificação de desempenho de mercado
Ação da Palisade Bio inicia cobertura com Outperform na Raymond James
Raymond James mantém recomendação para ações da Liquidia em meio a processos judiciais
Ginkgo Bioworks vai apoiar o programa NSF X-Labs com acesso a laboratório
AbCellera apresentará dados de fase 1/2 sobre candidato a medicamento para menopausa
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |